AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+7.64%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$17.2B
AUM Growth
+$1.4B
(+8.8%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
62.73%
Holding
1,140
New
150
Increased
453
Reduced
383
Closed
150
Top Buys
| 1 |
Hess Midstream
HESM
|
+$264M |
| 2 |
Energy Transfer Partners
ET
|
+$160M |
| 3 |
Sunoco
SUN
|
+$147M |
| 4 |
Western Midstream Partners
WES
|
+$98.3M |
| 5 |
Cheniere Energy
CQP
|
+$84.8M |
Top Sells
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$706M |
| 2 |
Cameco
CCJ
|
+$27.3M |
| 3 |
Fortuna Silver Mines
FSM
|
+$12M |
| 4 |
MPLX
MPLX
|
+$11.6M |
| 5 |
CVS Health
CVS
|
+$8.33M |
Sector Composition
| 1 | Energy | 69.95% |
| 2 | Technology | 3.96% |
| 3 | Financials | 3.32% |
| 4 | Consumer Discretionary | 3% |
| 5 | Utilities | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
RTX Corp
RTX
$203B
| $477K | ﹤0.01% |
+3,600
| New | +$477K |
|
602
Prothena Corp
PRTA
$449M
| $470K | ﹤0.01% |
37,956
-5,554
| -13% | -$68.7K |
|
603
ArriVent BioPharma
AVBP
$804M
| $465K | ﹤0.01% |
25,167
-2,085
| -8% | -$38.6K |
|
604
HCA Healthcare
HCA
$97.8B
| $460K | ﹤0.01% |
1,332
+413
| +45% | +$143K |
|
605
Ramaco Resources Class A
METC
$1.71B
| $460K | ﹤0.01% |
56,386
-2,868
| -5% | -$23.4K |
|
606
Vaalco Energy
EGY
$396M
| $457K | ﹤0.01% |
121,506
-66,318
| -35% | -$249K |
|
607
Duke Energy
DUK
$93.4B
| $456K | ﹤0.01% |
3,735
+1,068
| +40% | +$130K |
|
608
Ethan Allen Interiors
ETD
$760M
| $453K | ﹤0.01% |
16,349
-594
| -4% | -$16.5K |
|
|
BLDP
609
Ballard Power Systems
BLDP
$568M
| $437K | ﹤0.01% |
396,822
+8,265
| +2% | +$9.09K |
|
610
Nuvation Bio
NUVB
$1.15B
| $431K | ﹤0.01% |
245,126
-27,024
| -10% | -$47.6K |
|
611
AnaptysBio
ANAB
$621M
| $430K | ﹤0.01% |
23,126
-1,478
| -6% | -$27.5K |
|
612
Dianthus Therapeutics
DNTH
$1.14B
| $430K | ﹤0.01% |
23,684
-248
| -1% | -$4.5K |
|
613
Lifezone Metals
LZM
$364M
| $428K | ﹤0.01% |
102,384
+28,242
| +38% | +$118K |
|
614
Prologis
PLD
$104B
| $426K | ﹤0.01% |
3,809
+1,775
| +87% | +$198K |
|
615
Immunome
IMNM
$818M
| $421K | ﹤0.01% |
62,544
+12,074
| +24% | +$81.3K |
|
616
Gevo
GEVO
$389M
| $417K | ﹤0.01% |
359,641
+7,861
| +2% | +$9.12K |
|
617
Marriott International Class A Common Stock
MAR
$72.8B
| $415K | ﹤0.01% |
1,741
+503
| +41% | +$120K |
|
618
Clean Energy Fuels
CLNE
$544M
| $408K | ﹤0.01% |
263,455
+5,029
| +2% | +$7.8K |
|
619
TechnipFMC
FTI
$16.1B
| $403K | ﹤0.01% |
12,709
-1,441
| -10% | -$45.7K |
|
|
SLI
620
Standard Lithium
SLI
$571M
| $402K | ﹤0.01% |
316,244
+160,907
| +104% | +$204K |
|
621
Greif Class B
GEF.B
$2.46B
| $400K | ﹤0.01% |
6,745
-246
| -4% | -$14.6K |
|
622
Catalyst Pharmaceutical
CPRX
$2.46B
| $400K | ﹤0.01% |
16,476
-633
| -4% | -$15.4K |
|
623
W.R. Berkley
WRB
$27.5B
| $399K | ﹤0.01% |
5,611
-471
| -8% | -$33.5K |
|
624
IQVIA
IQV
$32.2B
| $397K | ﹤0.01% |
2,251
-880
| -28% | -$155K |
|
625
Pilgrim's Pride
PPC
$10.6B
| $395K | ﹤0.01% |
7,249
-1,451
| -17% | -$79.1K |
|